Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3897389
Max Phase: Preclinical
Molecular Formula: C40H55N3O9S
Molecular Weight: 753.96
Molecule Type: Small molecule
Associated Items:
ID: ALA3897389
Max Phase: Preclinical
Molecular Formula: C40H55N3O9S
Molecular Weight: 753.96
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](CO)[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O
Standard InChI: InChI=1S/C40H55N3O9S/c1-5-7-19-40(20-8-6-2)25-53(49,50)32-18-17-29(43(3)4)22-30(32)33(37(40)47)27-15-12-16-28(21-27)41-39(48)42-38-35(46)36(34(45)31(23-44)52-38)51-24-26-13-10-9-11-14-26/h9-18,21-22,31,33-38,44-47H,5-8,19-20,23-25H2,1-4H3,(H2,41,42,48)/t31-,33-,34-,35-,36+,37-,38-/m1/s1
Standard InChI Key: NAVXGANAZYCKRD-HANJNXQLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 753.96 | Molecular Weight (Monoisotopic): 753.3659 | AlogP: 4.55 | #Rotatable Bonds: 14 |
Polar Surface Area: 177.89 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.48 | CX Basic pKa: 2.23 | CX LogP: 4.76 | CX LogD: 4.76 |
Aromatic Rings: 3 | Heavy Atoms: 53 | QED Weighted: 0.14 | Np Likeness Score: 0.07 |
1. (2010) Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof, |
Source(1):